{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:49:12Z","timestamp":1781207352902,"version":"3.54.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/gco.0b013e328355871d","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T01:40:56Z","timestamp":1339551656000},"page":"235-240","source":"Crossref","is-referenced-by-count":46,"title":["Thrombotic risks of oral contraceptives"],"prefix":"10.1097","volume":"24","author":[{"given":"Hannelore","family":"Rott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210129","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1160\/TH07-03-0212","article-title":"Venous thromboembolism (VTE) in Europe The number of VTE events and associated morbidity and mortality.","volume":"98","author":"Cohen","year":"2007","journal-title":"Thromb Haemost"},{"key":"R3-8-20210129","first-page":"178","article-title":"Contraception and Thrombophilia: a statement from the German Society for Gynecological Endocrinology and Reproductive Medicine (DGGEF e.V.) and the Professional Association of German Gynaecologists (BVF e.V.).","volume":"8","author":"Rabe","year":"2011","journal-title":"J Reproduktionsmed Endokrinol"},{"key":"R4-8-20210129","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood-2011-03-345678","article-title":"Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception.","volume":"118","author":"Vlijmen EFW van, V Veeger","year":"2011","journal-title":"Blood"},{"key":"R5-8-20210129","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(99)01257-X","article-title":"Venous thromboembolism among new users of different oral contraceptives.","volume":"354","author":"Herings","year":"1999","journal-title":"Lancet"},{"key":"R6-8-20210129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation orals contraceptives and risk of venous thrombosis: meta-analysis.","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"R8-8-20210129","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0010-7824(01)00269-4","article-title":"The effects of two progestogen-only pills containing either desogestrel (75microgday) or levonorgestrel (30microgday) on lipid metabolism.","volume":"64","author":"Barkfeldt","year":"2001","journal-title":"Contraception"},{"key":"R9-8-20210129","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1538-7836.2007.02730.x","article-title":"Upregulation of protein S by progestins.","volume":"5","author":"Hughes","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R11-8-20210129","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1538-7836.2008.02863.x","article-title":"Different effects of oral contraceptives containing different progestogens on protein s and tissue factor pathway inhibitor.","volume":"6","author":"van Vliet","year":"2008","journal-title":"J Thromb"},{"key":"R12-8-20210129","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0010-7824(98)00045-6","article-title":"A randomized controlled double-blind study of the effects on hemostasis to two progeston-only pills containing 75g desogestrel or 30g levonorgestrel.","volume":"57","author":"Winkler","year":"1998","journal-title":"Contraception"},{"key":"R13-8-20210129","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA-case control study.","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"R14-8-20210129","first-page":"159","article-title":"Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valeratedienogest versus ethinylestradiollevonorgestrel.","volume":"11","author":"Klipping","year":"2011","journal-title":"Drugs"},{"key":"R15-8-20210129","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2165\/11590220-000000000-00000","article-title":"Metabolic and haemostatic effects of estradiol valeratedienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.","volume":"31","author":"Junge","year":"2011","journal-title":"Clin Drug Investig"},{"key":"R16-8-20210129","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/13625187.2011.604450","article-title":"Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism.","volume":"16","author":"Agren","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R17-8-20210129","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1160\/TH10-05-0327","article-title":"Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate17-estradiol, compared with those of levonorgestrelethinyl estradiol. A double-blind, randomised study.","volume":"105","author":"Gaussem","year":"2011","journal-title":"Thromb Haemost"},{"key":"R18-8-20210129","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1210\/jc.2007-0026","article-title":"Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study.","volume":"92","author":"Sitruk-Ware","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-8-20210129","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2006.01.001","article-title":"Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"R20-8-20210129","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0010-7824(98)00041-9","article-title":"Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives.","volume":"57","year":"1998","journal-title":"Contraception"},{"key":"R21-8-20210129","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device.","volume":"30","author":"van Hylckama Vlieg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R22-8-20210129","first-page":"539","article-title":"O, Farley TM, Sivin I, for the International Collaborative Postmarketing Surveillance of Norplant. Safety and efficacy of levonorgestrel implant, intrauterine device, and sterilization.","volume":"97","year":"2001","journal-title":"Obstet Gynaecol"},{"key":"R23-8-20210129","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)04394-9","article-title":"Risk of idiopathic venous thromboembolism in users of progestagens alone.","volume":"354","author":"Vasilakis","year":"1999","journal-title":"Lancet"},{"key":"R24-8-20210129","first-page":"1513","article-title":"A multinational case-control study of cardiovascular disease and steroid hormone contraceptives.","volume":"48","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-8-20210129","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)03132-3","article-title":"Risk of cardiovascular diseases associated with oral progestogen preparations with therapeutic indications.","volume":"354","author":"Poulter","year":"1999","journal-title":"Lancet"}],"container-title":["Current Opinion in Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GCO.0b013e328355871d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:18:36Z","timestamp":1620951516000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001703-201208000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/gco.0b013e328355871d","relation":{},"ISSN":["1040-872X"],"issn-type":[{"value":"1040-872X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}